Well Connected

Our competitive advantage derives from our vast network of suppliers, buyers and local non-profit groups.

Discrete

We believe in maintaining the privacy of our suppliers and customers. The security of our network is of utmost importance.

Ethical

Our goal is to conduct business with integrity, carefully observing local laws and always abstaining from corruption.

Socially Responsible

We aim to inspire and improve local communities through knowledge transfer and infrastructural advancements.


Community Building:

GLS is committed to improving the living conditions in rural communities in developing countries by establishing Self-Sustaining Communities. We are partnering with local governments and community leaders to help create job opportunities as well as construct essential infrastructures such as roads, schools, and agricultural projects.

We are confident that our Self Sustaining Community model will provide citizens in rural communities the opportunities to develop vital job skills and learn trades that will enable them to become active producing members of society and contribute to the growth and development of their countries as a whole.

  • Rural Poverty Rate 70%
  • Average Unemployment 35%
  • Average Urban Growth Rate 18%
  • Projected Urban Population Rate by 2020: 63%

Global Healthcare:

At GLS, we have launched a strategic program for non-communicable diseases such as diabetes and cardiovascular illness.

These health conditions have created serious economic and developmental challenges globally and have been linked to the loss of Productivity, rising health costs, and poverty.

The focus of our global health initiative is to integrate national economic development programs with clear directions in respect to patient recovery outcomes. This will be accomplished by utilizing data generated from research to create a clearly defined national drug formulary with an emphasis on cost effectiveness and reducing wasteful inventory.

  • Increased Economical Burden due to CV disease by 2030 22%
  • % Diabetes Related Deaths in Developing Countries 80%
  • Cardiovascular Related Deaths 12.5%
  • Prevalence of Diabetes 6%